Concussions in sports are known to have a long-term impact on athletes’ health, but does that include Parkinson’s disease? NewYork-Presbyterian experts provide insight on whether they can raise the risk of this neurological condition and what to know about the impact of repeated head injuries.
Lecanemab and donanemab, antibody treatments administered intravenously, are the latest therapies clinically proven to slow the rate of cognitive decline.